Shandong, China

Jinlong Ma

This inventor holds 2 USPTO granted patents and 1 published patent application. Top assignees: Shandong University, Shandong Shanda Hospital for Reproductive Medicine Co., Ltd., Shanghai Jiao Tong University. Active years: 2014-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Jinlong Ma. Retrieved from https://idiyas.com/inventor/jinlong-ma-xx1v5n16

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 2 

% Patents Active = 50.0

Average Co-Inventor Count = 8.0

ph-index = 1


Company Filing History:


Years Active: 2014-2026

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Innovations of Jinlong Ma in Polycystic Ovary Syndrome Research

Introduction

Jinlong Ma is a notable inventor based in Shandong, China. He has made significant contributions to the field of reproductive medicine, particularly in understanding polycystic ovary syndrome (PCOS). His work focuses on the genetic markers associated with this condition, which affects many women worldwide.

Latest Patents

Jinlong Ma holds a patent for SNP markers associated with polycystic ovary syndrome. The present invention discloses SNP markers related to PCOS and provides probes, chips, primers, kits, and methods for detecting these markers. Furthermore, the invention relates to the use of SNPs in predicting or diagnosing the risk of PCOS.

Career Highlights

Throughout his career, Jinlong Ma has worked with esteemed institutions such as Shandong University and Shandong Shanda Hospital for Reproductive Medicine Co., Ltd. His research has been pivotal in advancing the understanding of PCOS and its genetic underpinnings.

Collaborations

Jinlong Ma has collaborated with notable colleagues, including Zi-Jiang Chen and Han Zhao. Their combined efforts have contributed to the advancement of research in reproductive health.

Conclusion

Jinlong Ma's innovative work in identifying SNP markers for polycystic ovary syndrome represents a significant advancement in the field of reproductive medicine. His contributions are essential for improving diagnosis and treatment options for women affected by this condition.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…